Abstract
Cardiovascular diseases remained as major cause of mortality worldwide due to atherosclerosis. The CETP is a glycoprotein, which promote the lipid transfer between plasma apolipoprotein B lipoprotein to HDL. Although CETP activity leads to decreases in HDL-cholesterol plasma levels, clinical tests using CETP inhibitors showed no benefits or increased mortality. Experimental evidence sugge…